On October 23, 2025, Intelligent Bio Solutions Inc. announced it had secured a major new contract with one of the United Kingdom’s largest industrial service providers. The multinational company, which operates across energy, defence, nuclear and industrial sectors, employs more than 30,000 people worldwide and 3,000 in the UK and Ireland. The deal represents one of INBS’s most significant UK commercial deployments to date.
Under the agreement, the industrial service provider will transition from its existing urine‑based testing program to INBS’s Intelligent Fingerprinting Drug Screening System. The provider expects faster, cleaner, and more efficient testing that reduces downtime, increases productivity, and delivers rapid results at the point of testing. The switch also improves employee experience by offering a less invasive method and shorter detection windows.
The contract is a key milestone for INBS, reinforcing market confidence in its non‑invasive fingerprint sweat‑based technology and expanding its recurring cartridge revenue stream. With the addition of another large enterprise customer, INBS’s customer base now exceeds 480 accounts in 24 countries, supported by 18 distribution partners. The win underscores the company’s ability to scale its razor‑blade business model in safety‑critical industries.
INBS continues to broaden its international footprint while advancing its FDA 510(k) clearance pathway for entry into the U.S. workplace testing market. The company’s technology, which delivers results in under ten minutes, has already gained traction in transportation, construction, mining, and drug treatment sectors outside the United States. The new UK contract further positions INBS to capture growth in the global drug‑testing market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.